0001209191-20-050615.txt : 20200915 0001209191-20-050615.hdr.sgml : 20200915 20200915213753 ACCESSION NUMBER: 0001209191-20-050615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200911 FILED AS OF DATE: 20200915 DATE AS OF CHANGE: 20200915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEST MICHAEL D CENTRAL INDEX KEY: 0001202529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 201177284 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE, SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AgeX Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821436829 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 510-671-8370 MAIL ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-11 0 0001708599 AgeX Therapeutics, Inc. AGE 0001202529 WEST MICHAEL D 965 ATLANTIC AVENUE, SUITE 101 ALAMEDA CA 94501 1 1 0 0 Chief Executive Officer Common Stock, $0.0001 par value 2020-09-11 4 M 0 3125 0.00 A 29635 D Common Stock, $0.0001 par value 2020-09-11 4 F 0 1081 0.8095 D 28554 D Restricted Stock Units 0.00 2020-09-11 4 M 0 3125 0.00 D Common Stock 3125 31250 D Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Restricted Stock Units vested on September 11, 2020. /s/Michael D. West 2020-09-15